ANUH PHARMA LIMITED Share Price

ANUH PHARMA LIMITED Share Price

NSE: ANUHPHR
|
Pharmaceuticals
|
S Cap
₹ 90.29
+₹9.19 (11.33%)
1D
Last updated 07 Sep, 2026, 15:59 IST

ANUH PHARMA LIMITED Share Price Today

As of 7 Sep 2026, ANUH PHARMA LIMITED share price is ₹90.29. The stock opened at ₹82.70, compared to its previous close of ₹81.10. During today's trading session, ANUH PHARMA LIMITED share price moved in the range of ₹82.00 to ₹91.80, with an average price of ₹86.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.00 and a high of ₹93.00. On the performance front, ANUH PHARMA LIMITED share price has increased by 6.74% over the last six months and is down 5.06% on a year-on-year basis.

₹82.00
11.33% up today
₹91.80
1D LOW
1D HIGH

ANUH PHARMA LIMITED Returns Calculator

Circuit
L
H
₹64.88
₹97.32
52-week
L
H
₹67.00
₹93.00

About ANUH PHARMA LIMITED

ANUH PHARMA LIMITED Share Price
ISIN
INE489G01022
Sector Market Cap
₹ 814.22 Cr

Anuh Pharma Limited is engaged in the business of manufacturing and selling bulk drugs and chemicals. The Company's products include active pharmaceutical ingredients and corticosteroids. Its active pharmaceutical ingredients include macrolides, anti-TB, anti-malarial, antibacterial, anti-hypertension, expectorant, quinolones, intermediates and under development. Its macrolides products include erythromycin, erythromycin ethyl succinate, erythromycin stearate, erythromycin estolate, erythromycin propionate, erythromycin phosphate, and others. Its anti-malarial products include sulfadoxine, pyrimethamine, and others. The Company's anti-hypertension products include losartan potassium, telmisartan and atorvastatin calcium. The Company's corticosteroids include anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, antihistamines and under development. Its anti-inflammatory products include dexamethasone Na phosphate, mometasone furoate and clobetasol butyrate.

ANUH PHARMA LIMITED Financial Highlights

  • Revenue: ANUH PHARMA LIMITED reported revenue of ₹776.02 crore in FY26 vs ₹670.97 crore in FY25. It showed an increase of 15.66% on a yearly basis.
  • Operating Profit: ANUH PHARMA LIMITED reported an operating profit of ₹54.22 crore in FY26 vs ₹61.01 crore in FY25. It showed a decrease of 11.13% on a year-on-year basis.
  • Net Profit: ANUH PHARMA LIMITED reported a net profit of ₹41.05 crore in FY26 vs ₹47.35 crore in FY25. It showed a decrease of 13.31% on a yearly basis.

ANUH PHARMA LIMITED Quarterly Result Highlights

  • ANUH PHARMA LIMITED reported revenue of ₹196.89 crore in Jun 2026, compared with ₹200.87 crore in Mar 2026, representing a decrease of 1.98% on a quarter-on-quarter (QoQ) basis.
  • ANUH PHARMA LIMITED reported an operating profit of ₹16.93 crore in Jun 2026, compared with ₹15.52 crore in Mar 2026, representing an increase of 9.09% on a quarter-on-quarter (QoQ) basis.
  • ANUH PHARMA LIMITED reported a profit of ₹11.42 crore in Jun 2026, compared with ₹11.68 crore in Mar 2026, reflecting a decrease of 2.23% on a QoQ basis.
  • The earnings per share (EPS) of ANUH PHARMA LIMITED stood at ₹4.10 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
71.80%
FII
0.01%
Other DII
0.00%
Retail and other
28.19%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.05%
Jun 20260.01%
Mkt Cap Cr
814.22
P/E
18.42
P/B
2.31
ROE
11.65%
D/E
0.00
ROCE
15.53%
Div. Yield
1.85%
EPS(TTM)
4.10
Turnover
1.40
EV/EBITDA
11.21
Net Margin
5.32%
Op. Margin
8.63%
ROA
7.92%
Quick Ratio
1.50
Curr. Ratio
2.22
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Anuh Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Anuh Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,55,634.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,41,576.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Cipla1,11,888.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Zydus Lifesciences1,11,820.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin96,528.8017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Dr. Reddy's Laboratories96,322.1030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,127.2025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ANUH PHARMA LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹771.66₹661.51₹647.00₹527.49
Other Income₹4.36₹9.46₹12.10₹6.11
Total Revenue₹776.01₹670.97₹659.10₹533.60
Total Expenses₹721.79₹609.96₹580.79₹486.13
Profit Before Tax₹54.22₹61.01₹78.31₹47.47
Tax₹13.18₹13.65₹18.25₹11.29
Profit After Tax₹41.05₹47.35₹60.06₹36.18
EPS - Basic₹4.10₹9.45₹11.98₹7.22
EPS - Diluted₹4.10₹9.45₹11.98₹7.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹54.22₹61.01₹78.31₹47.47
Income before WC changes₹65.14₹61.33₹75.58₹51.00
Change in Assets-₹82.21-₹30.84-₹32.34-₹17.85
Change in Liabilities₹27.30₹17.76-₹11.24₹34.21
Change in WC-₹54.91-₹13.09-₹43.58₹16.37
Cash flow from Operations-₹3.01₹37.12₹12.93₹53.90
Cash flow from Investing₹17.84-₹19.91₹0.92-₹43.48
Cash flow from Financing-₹26.33-₹4.86-₹8.57-₹12.29
Total Cash Flow-₹11.50₹12.36₹5.27-₹1.87
Cash (Start of the year)₹19.56₹7.20₹1.93₹3.80
Cash (End of the year)₹8.06₹19.56₹7.20₹1.93

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹106.05₹130.46₹107.14₹97.37
Current Assets₹451.32₹376.17₹338.54₹307.61
Total Assets₹557.37₹506.63₹445.68₹404.98
Current Liabilities₹203.00₹178.51₹152.69₹161.34
Net Current Asset₹248.31₹197.66₹185.84₹146.28
Non-Current Liabilities₹2.14₹2.09₹1.77₹2.42
Equity Capital₹352.22₹326.02₹291.22₹241.22
Total Equity & Liabilities₹557.37₹506.63₹445.68₹404.98
* All values are in INR Crore
Qty
Bid
13678
90.29
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 13678
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
56.11
Neutral
ATR (14)
2.81
Neutral
STOCH(9,6)
45.61
Neutral
STOCH RSI (14)
63.79
Neutral
ADX(9)
26.16
Bearish
UO(9)
46.22
Neutral
ROC(12)
6.91
Bullish
WillR(14)
-46.18
Neutral
Period
Simple value
Exponential vaue
5D
80.64
80.54
10D
80.55
80.14
20D
78.53
79.51
50D
79.26
79.08
100D
79.28
78.85
Volume trend — traded volume by day
7 Sep10L
4 Sep0L
3 Sep0L
2 Sep1L
1 Sep0L
31 Aug0L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ANUH PHARMA LIMITED Share Price
ANUH PHARMA LIMITED
Pharmaceuticals
Add Stock
Add Another

ANUH PHARMA LIMITED Share Price FAQs

ANUH PHARMA LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837